Pay in 4 interest-free payments of $27.23 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
121345-64-0
NVP-BEZ235 and NVP-BGT226
is a next-generation proteasome inhibitor with demonstrated preclinical and clinical antimyeloma activity
GSK2801 was used at 10 µM final concentration in vitro and in cellular assays
is an antifungal lipopeptide that acts by inhibiting the synthesis of β-(1
Emricasan Catalog No.:M10978-10 121345-64-0Emricasan, also known as IDN 6556 and PF 03491390, is a first in class caspase inhibitor in clinical trials for the treatment of liver diseases. Emricasan (IDN 6556) decreases liver injury and fibrosis in a murine model of non alcoholic steatohepatitis. IDN6556 facilitates marginal mass islet engraftment in a porcine islet autotransplant model. Oral IDN 6556 may lower aminotransferase activity in patients with chronic hepatitis C. Orally administered
US$ 129.00
US$ 22.99
US$ 111.95
US$ 11.95
US$ 49.99
US$ 39.99
US$ 94.99
US$ 12.99
US$ 23.95
US$ 88.95
US$ 29.99